Redefining Pharmaceutical Research and Training with Digital Twins and AI
Next-generation Water Systems in Pharma
Microbiological QC Bottlenecks in Biopharma
Fine-tuning AI Models for Molecular Co-folding
Why Pharma Products still go to Waste and How Better Logistics can Help
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
ExpreS2ion Biotechnologies
Vice President - Business Development
ExpreSion Biotechnologies protein expression system ExpreS is an important protein expression tool in the scientists tool box for protein expression The ExpreS platform has demonstrated in many instances its usefulness in RD with several ExpreSmade proteins having now been crystallized
Articles
The Green Revolution in Medicine
The term Green Revolution originally referred to the agricultural transformation of the s when scientific advances dramatically increased food production and reshaped global food security That revolution changed the world by solving a critical human challenge hunger Yet today humanity faces a new crisis that is equally
Research Insights
Uncovering Key Biomarkers, Potential Therapeutic Targets and Development of Deep Learning Model in Heart Failure
Heart failure HF represents a significant public health concern characterized by elevated rates of mortality and morbidity Recent advancements in gene sequencing technologies have led
Case Studies
Pediatrician’s Cough And Cold Medication Prescription For Hypothetical Cases: A Cross-Sectional Multi-Centric Case Study
Abstract Cough and cold is the most common cause for hospital visits and so is the use of cough and cold medication CCM A cough and cold medication has been considered to contain a single ingredient SI or multiple ingredients MI like promethazine PRZ chlorpheniramine CPM pseudoephedrine PS phenylephrine PE diphenhydramine DPH dextromethor
Techno Trends
Chimeric Therapeutics Unveils Novel CHM 2101 Cell Therapy for Advanced Gastrointestinal Cancers
Chimeric Therapeutics has introduced a groundbreaking therapy named CHM representing a pioneering CDH CAR T cell treatment engineered specifically for gastrointestinal cancers
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Advanced Drug Delivery Systems for Chronic Liver Disease Management
Associate Professor, College of Pharmacy at University of Rhode Island
Is Convex Dose Dependence A Side Effect That Multiple Drug Treatment Causes?
Professor, Chuo University
Assistant Professor, King Abdulaziz University
Determinants of Antimicrobial Resistance (AMR) Research in South East Asia
Scientist, Indian Council of Medical Research
Doctoral Scholar, Department of Pharmaceutical Technology
press releasesRead more...
SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs
SK pharmteco today announced a strategic partnership with Axle Informatics and the National Institutes of Health NIH to advance the development of gene therapies for rare diseases This partnership focused on viral vector programs underscores SK pharmtecos commitment
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
Novartis a leading global innovative medicines company today broke ground on its new sq ft radioligand therapy RLT manufacturing site in Denton Texas the latest milestone in its broader billion investment in US manufacturing and research The start of construction
Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation
Taimei Technology HK a leading AIpowered drug clinical development platform company and CR Research A a toptier CRO in South Korea signed an enterpriselevel strategic partnership agreement
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
Cartography Biosciences and Samsung Ventures today announced a strategic investment to support the advancement of Cartographys differentiated oncology pipeline and expand its proprietary drug discovery platform
Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program
Waiv formerly Owkin Dx a Parisbased company catalyzing AI precision testing today announced it has entered a collaboration with Daiichi Sankyo TSE to lead digital pathology biomarker discovery for an antibodydrug conjugate ADC program
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
Vertex Pharmaceuticals Incorporated announced today that a reimbursement agreement was signed with the GKVSpitzenverband for its CRISPRCas geneedited therapy CASGEVY exagamglogene autotemcel This agreement secures sustainable access to this innovative
EventsRead more...
10 - 14
May 2026Respiratory Drug Delivery 2026
The Westin Kierland Phoenix, Arizona, USA
12 - 13
May 2026PDA Pharmaceutical Manufacturing 2026
Singapore
14 - 14
May 2026PDA Microbiology in CCS Workshop 2026
Singapore
20 - 21
May 2026Pharmacovigilance Europe 2026
London, UK
20 - 21
May 2026Pharma Partnering EU Summit 2026
Pharma Partnering Summit
Basel Marriott Hotel, Switzerland
20 - 22
May 2026PHARMA EURASIA 2026
Pharma & Med Tech Park, Tashkent, Uzbekistan
21 - 22
May 2026Liver Diseases & Hepatology 2026
Paris, France
27 - 28
May 2026Digi-Tech Pharma & AI Conference
London, United Kingdom
LATEST NEWSRead more...
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
Altasciences a fully integrated drug development solution company and Certara a global leader in modelinformed drug development MIDD today announced a strategic partnership to accelerate earlyphase development programs
Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets
Halozyme Therapeutics Inc announced the Company entered into a global collaboration and license agreement with GSK Under the collaboration GSK has licensed Halozymes ENHANZE drug delivery technology for the development and potential commercialization of subcutaneous administration
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
Roche announced today that it has entered into a definitive merger agreement to acquire PathAI a USbased company in digital pathology and AIpowered technology for pathology laboratories and the biopharma industry
Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer
Artera the developer of multimodal artificial intelligence MMAIbased prognostic and predictive cancer tests today announced US Food and Drug Administration FDA clearance of ArteraAI Breast for use in patients with earlystage
FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media
FUJIFILM Biosciences a global leader in the life science market and NextCell Pharma AB a clinicalstage company specializing in cell therapy using umbilical cord mesenchymal stromal cells MSC today announced a global commercial launch resulting from their strategic collaboration
Merck Completes Acquisition of Terns Pharmaceuticals
Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals
